Michael Riskalla

Michael Riskalla practices at Jersey City Medical Center in Jersey City, New Jersey, part of RWJBarnabas Health.

Michael Riskalla's NPI, 1538628631, was assigned on March 18, 2019. Michael Riskalla holds Massachusetts license 294844.

Michael Riskalla's primary practice is Jersey City Medical Center, at 355 Grand Street, Jersey City, NJ 07302 in Hudson County. The practice phone is (201) 915-2000.

Michael Riskalla's primary practice is Jersey City Medical Center in Jersey City, New Jersey, part of RWJBarnabas Health. Michael Riskalla is also affiliated with Newark Beth Israel Medical Center. The medical group on file is RWJBarnabas Health Medical Group. Dmand AI also links Michael Riskalla to 1 more hospital and 5 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Michael Riskalla practices, 3 sites in all. Vendor and product names are available with a free account.

Hospitalist is Michael Riskalla's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Michael Riskalla is licensed in Massachusetts.

CMS data shows 847 Medicare services from Michael Riskalla across 6 procedure codes in 2024, for 446 Medicare patients. Medicare paid $69,702 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 446 Medicare patients who saw Michael Riskalla in 2024. The largest group is 75 to 84, with 164 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 29% are also on Medicaid. Their average risk score is 2.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Michael Riskalla's median patient age at 69, with 53% women.

In 2024, Michael Riskalla wrote 291 Medicare Part D claims for 140 patients. 91% of them were for generic drugs. CMS names the drug for 115 of them, across 8 drugs with 11 or more claims each, at $1,059 in total drug cost. In 2023, CMS named 142 claims across 8 drugs.

Michael Riskalla accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 4 general payments to Michael Riskalla from 4 drug and device companies from 2023 to 2024. Food and beverage make up the largest share, 100% of the total. Takeda Pharmaceuticals U.S.A., Inc. paid the most, $38.